Global Antiulcer Agents and Acid Suppressants Production, Demand and Key Producers, 2022-2028

October 2022 | 134 pages | ID: GCE6A66F3791EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Antiulcer Agents and Acid Suppressants demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antiulcer Agents and Acid Suppressants, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiulcer Agents and Acid Suppressants that contribute to its increasing demand across many markets.

The global Antiulcer Agents and Acid Suppressants market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Antiulcer Agents and Acid Suppressants total market, 2017-2028, (USD Million)

Global Antiulcer Agents and Acid Suppressants total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Antiulcer Agents and Acid Suppressants total market, key domestic companies and share, (USD Million)

Global Antiulcer Agents and Acid Suppressants revenue by player and market share 2017-2022, (USD Million)

Global Antiulcer Agents and Acid Suppressants total market by Type, CAGR, 2017-2028, (USD Million)

Global Antiulcer Agents and Acid Suppressants total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Antiulcer Agents and Acid Suppressants market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sandoz, Alcon, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Takeda, Camber Pharmaceuticals, Carlsbad Technologies and Advagen Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiulcer Agents and Acid Suppressants market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Antiulcer Agents and Acid Suppressants Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Antiulcer Agents and Acid Suppressants Market, Segmentation by Type
  • 10 mg
  • 20 mg
  • 30 mg
  • 100 mg
  • Others
Global Antiulcer Agents and Acid Suppressants Market, Segmentation by Application
  • Hospital
  • Clinics
  • Pharmacy
  • Others
Companies Profiled:
  • Pfizer
  • Sandoz
  • Alcon
  • Teva Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Takeda
  • Camber Pharmaceuticals
  • Carlsbad Technologies
  • Advagen Pharma
  • Gavis Pharmaceuticals
  • Generic
  • Akorn
  • Lannett
  • Lupin Pharmaceuticals
  • Methaparm
  • Nostrum Laboratories
  • Precision Dose
  • Athenex
  • AuroMedics Pharma
  • Fresenius Kabi
  • Astra Zeneca Pharm
  • Glenmark Pharmaceuticals
  • Aurobindo Pharma
Key Questions Answered

1. How big is the global Antiulcer Agents and Acid Suppressants market?

2. What is the demand of the global Antiulcer Agents and Acid Suppressants market?

3. What is the year over year growth of the global Antiulcer Agents and Acid Suppressants market?

4. What is the total value of the global Antiulcer Agents and Acid Suppressants market?

5. Who are the major players in the global Antiulcer Agents and Acid Suppressants market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Antiulcer Agents and Acid Suppressants Introduction
1.2 World Antiulcer Agents and Acid Suppressants Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Antiulcer Agents and Acid Suppressants Total Market by Region
  1.3.1 World Antiulcer Agents and Acid Suppressants Market Size by Region (2017-2028)
  1.3.2 United States Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.3 China Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.4 Europe Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.5 Japan Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.6 South Korea Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.7 ASEAN Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
  1.3.8 India Antiulcer Agents and Acid Suppressants Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Antiulcer Agents and Acid Suppressants Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Antiulcer Agents and Acid Suppressants Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD ANTIULCER AGENTS AND ACID SUPPRESSANTS COMPANIES COMPETITIVE ANALYSIS

2.1 World Antiulcer Agents and Acid Suppressants Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Antiulcer Agents and Acid Suppressants Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Antiulcer Agents and Acid Suppressants in 2021
  2.2.3 Global Concentration Ratios (CR8) for Antiulcer Agents and Acid Suppressants in 2021
2.3 Antiulcer Agents and Acid Suppressants Company Evaluation Quadrant
2.4 Antiulcer Agents and Acid Suppressants Market: Overall Company Footprint Analysis
  2.4.1 Antiulcer Agents and Acid Suppressants Market: Region Footprint
  2.4.2 Antiulcer Agents and Acid Suppressants Market: Company Product Type Footprint
  2.4.3 Antiulcer Agents and Acid Suppressants Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Antiulcer Agents and Acid Suppressants Market Comparison
  3.1.1 United States VS China: Antiulcer Agents and Acid Suppressants Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Antiulcer Agents and Acid Suppressants Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Antiulcer Agents and Acid Suppressants Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Antiulcer Agents and Acid Suppressants in United States, Headquarters (States, Country)
  3.2.2 United States Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022)
3.3 China Antiulcer Agents and Acid Suppressants Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Antiulcer Agents and Acid Suppressants in China, Headquarters (Province, Country)
  3.3.2 China Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Antiulcer Agents and Acid Suppressants Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Antiulcer Agents and Acid Suppressants in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Antiulcer Agents and Acid Suppressants Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 10 mg
  4.2.2 20 mg
  4.2.3 30 mg
  4.2.4 100 mg
  4.2.5 Others
4.3 Market Segment by Type
  4.3.1 World Antiulcer Agents and Acid Suppressants Market Size by Type (2017-2022)
  4.3.2 World Antiulcer Agents and Acid Suppressants Market Size by Type (2023-2028)
  4.3.3 World Antiulcer Agents and Acid Suppressants Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Antiulcer Agents and Acid Suppressants Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospital
  5.2.2 Clinics
  5.2.3 Pharmacy
  5.2.4 Others
  5.2.5 Others
5.3 Market Segment by Application
  5.3.1 World Antiulcer Agents and Acid Suppressants Market Size by Application (2017-2022)
  5.3.2 World Antiulcer Agents and Acid Suppressants Market Size by Application (2023-2028)
  5.3.3 World Antiulcer Agents and Acid Suppressants Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Pfizer
  6.1.1 Pfizer Details
  6.1.2 Pfizer Major Business
  6.1.3 Pfizer Antiulcer Agents and Acid Suppressants Product and Services
  6.1.4 Pfizer Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Pfizer Recent Developments/Updates
  6.1.6 Pfizer Competitive Strengths & Weaknesses
6.2 Sandoz
  6.2.1 Sandoz Details
  6.2.2 Sandoz Major Business
  6.2.3 Sandoz Antiulcer Agents and Acid Suppressants Product and Services
  6.2.4 Sandoz Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Sandoz Recent Developments/Updates
  6.2.6 Sandoz Competitive Strengths & Weaknesses
6.3 Alcon
  6.3.1 Alcon Details
  6.3.2 Alcon Major Business
  6.3.3 Alcon Antiulcer Agents and Acid Suppressants Product and Services
  6.3.4 Alcon Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Alcon Recent Developments/Updates
  6.3.6 Alcon Competitive Strengths & Weaknesses
6.4 Teva Pharmaceuticals
  6.4.1 Teva Pharmaceuticals Details
  6.4.2 Teva Pharmaceuticals Major Business
  6.4.3 Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
  6.4.4 Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Teva Pharmaceuticals Recent Developments/Updates
  6.4.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
6.5 Sun Pharmaceutical Industries
  6.5.1 Sun Pharmaceutical Industries Details
  6.5.2 Sun Pharmaceutical Industries Major Business
  6.5.3 Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Product and Services
  6.5.4 Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
  6.5.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
6.6 Takeda
  6.6.1 Takeda Details
  6.6.2 Takeda Major Business
  6.6.3 Takeda Antiulcer Agents and Acid Suppressants Product and Services
  6.6.4 Takeda Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Takeda Recent Developments/Updates
  6.6.6 Takeda Competitive Strengths & Weaknesses
6.7 Camber Pharmaceuticals
  6.7.1 Camber Pharmaceuticals Details
  6.7.2 Camber Pharmaceuticals Major Business
  6.7.3 Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
  6.7.4 Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 Camber Pharmaceuticals Recent Developments/Updates
  6.7.6 Camber Pharmaceuticals Competitive Strengths & Weaknesses
6.8 Carlsbad Technologies
  6.8.1 Carlsbad Technologies Details
  6.8.2 Carlsbad Technologies Major Business
  6.8.3 Carlsbad Technologies Antiulcer Agents and Acid Suppressants Product and Services
  6.8.4 Carlsbad Technologies Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Carlsbad Technologies Recent Developments/Updates
  6.8.6 Carlsbad Technologies Competitive Strengths & Weaknesses
6.9 Advagen Pharma
  6.9.1 Advagen Pharma Details
  6.9.2 Advagen Pharma Major Business
  6.9.3 Advagen Pharma Antiulcer Agents and Acid Suppressants Product and Services
  6.9.4 Advagen Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Advagen Pharma Recent Developments/Updates
  6.9.6 Advagen Pharma Competitive Strengths & Weaknesses
6.10 Gavis Pharmaceuticals
  6.10.1 Gavis Pharmaceuticals Details
  6.10.2 Gavis Pharmaceuticals Major Business
  6.10.3 Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
  6.10.4 Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.10.5 Gavis Pharmaceuticals Recent Developments/Updates
  6.10.6 Gavis Pharmaceuticals Competitive Strengths & Weaknesses
6.11 Generic
  6.11.1 Generic Details
  6.11.2 Generic Major Business
  6.11.3 Generic Antiulcer Agents and Acid Suppressants Product and Services
  6.11.4 Generic Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.11.5 Generic Recent Developments/Updates
  6.11.6 Generic Competitive Strengths & Weaknesses
6.12 Akorn
  6.12.1 Akorn Details
  6.12.2 Akorn Major Business
  6.12.3 Akorn Antiulcer Agents and Acid Suppressants Product and Services
  6.12.4 Akorn Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.12.5 Akorn Recent Developments/Updates
  6.12.6 Akorn Competitive Strengths & Weaknesses
6.13 Lannett
  6.13.1 Lannett Details
  6.13.2 Lannett Major Business
  6.13.3 Lannett Antiulcer Agents and Acid Suppressants Product and Services
  6.13.4 Lannett Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.13.5 Lannett Recent Developments/Updates
  6.13.6 Lannett Competitive Strengths & Weaknesses
6.14 Lupin Pharmaceuticals
  6.14.1 Lupin Pharmaceuticals Details
  6.14.2 Lupin Pharmaceuticals Major Business
  6.14.3 Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
  6.14.4 Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.14.5 Lupin Pharmaceuticals Recent Developments/Updates
  6.14.6 Lupin Pharmaceuticals Competitive Strengths & Weaknesses
6.15 Methaparm
  6.15.1 Methaparm Details
  6.15.2 Methaparm Major Business
  6.15.3 Methaparm Antiulcer Agents and Acid Suppressants Product and Services
  6.15.4 Methaparm Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.15.5 Methaparm Recent Developments/Updates
  6.15.6 Methaparm Competitive Strengths & Weaknesses
6.16 Nostrum Laboratories
  6.16.1 Nostrum Laboratories Details
  6.16.2 Nostrum Laboratories Major Business
  6.16.3 Nostrum Laboratories Antiulcer Agents and Acid Suppressants Product and Services
  6.16.4 Nostrum Laboratories Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.16.5 Nostrum Laboratories Recent Developments/Updates
  6.16.6 Nostrum Laboratories Competitive Strengths & Weaknesses
6.17 Precision Dose
  6.17.1 Precision Dose Details
  6.17.2 Precision Dose Major Business
  6.17.3 Precision Dose Antiulcer Agents and Acid Suppressants Product and Services
  6.17.4 Precision Dose Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.17.5 Precision Dose Recent Developments/Updates
  6.17.6 Precision Dose Competitive Strengths & Weaknesses
6.18 Athenex
  6.18.1 Athenex Details
  6.18.2 Athenex Major Business
  6.18.3 Athenex Antiulcer Agents and Acid Suppressants Product and Services
  6.18.4 Athenex Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.18.5 Athenex Recent Developments/Updates
  6.18.6 Athenex Competitive Strengths & Weaknesses
6.19 AuroMedics Pharma
  6.19.1 AuroMedics Pharma Details
  6.19.2 AuroMedics Pharma Major Business
  6.19.3 AuroMedics Pharma Antiulcer Agents and Acid Suppressants Product and Services
  6.19.4 AuroMedics Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.19.5 AuroMedics Pharma Recent Developments/Updates
  6.19.6 AuroMedics Pharma Competitive Strengths & Weaknesses
6.20 Fresenius Kabi
  6.20.1 Fresenius Kabi Details
  6.20.2 Fresenius Kabi Major Business
  6.20.3 Fresenius Kabi Antiulcer Agents and Acid Suppressants Product and Services
  6.20.4 Fresenius Kabi Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.20.5 Fresenius Kabi Recent Developments/Updates
  6.20.6 Fresenius Kabi Competitive Strengths & Weaknesses
6.21 Astra Zeneca Pharm
  6.21.1 Astra Zeneca Pharm Details
  6.21.2 Astra Zeneca Pharm Major Business
  6.21.3 Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Product and Services
  6.21.4 Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.21.5 Astra Zeneca Pharm Recent Developments/Updates
  6.21.6 Astra Zeneca Pharm Competitive Strengths & Weaknesses
6.22 Glenmark Pharmaceuticals
  6.22.1 Glenmark Pharmaceuticals Details
  6.22.2 Glenmark Pharmaceuticals Major Business
  6.22.3 Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
  6.22.4 Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.22.5 Glenmark Pharmaceuticals Recent Developments/Updates
  6.22.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
6.23 Aurobindo Pharma
  6.23.1 Aurobindo Pharma Details
  6.23.2 Aurobindo Pharma Major Business
  6.23.3 Aurobindo Pharma Antiulcer Agents and Acid Suppressants Product and Services
  6.23.4 Aurobindo Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022)
  6.23.5 Aurobindo Pharma Recent Developments/Updates
  6.23.6 Aurobindo Pharma Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Antiulcer Agents and Acid Suppressants and Key Manufacturers
7.2 Antiulcer Agents and Acid Suppressants Manufacturing Costs
7.3 Antiulcer Agents and Acid Suppressants Production Process
7.4 Antiulcer Agents and Acid Suppressants Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Antiulcer Agents and Acid Suppressants Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Antiulcer Agents and Acid Suppressants Typical Distributors
8.3 Antiulcer Agents and Acid Suppressants Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Antiulcer Agents and Acid Suppressants Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Antiulcer Agents and Acid Suppressants Market Size by Region (2017-2022) & (USD Million)
Table 3. World Antiulcer Agents and Acid Suppressants Market Size by Region (2023-2028) & (USD Million)
Table 4. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Region (2017-2022)
Table 5. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Antiulcer Agents and Acid Suppressants Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Antiulcer Agents and Acid Suppressants Players in 2021
Table 9. World Antiulcer Agents and Acid Suppressants Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Antiulcer Agents and Acid Suppressants Company Evaluation Quadrant
Table 11. Head Office of Key Antiulcer Agents and Acid Suppressants Player
Table 12. Antiulcer Agents and Acid Suppressants Market: Company Product Type Footprint
Table 13. Antiulcer Agents and Acid Suppressants Market: Company Product Application Footprint
Table 14. Antiulcer Agents and Acid Suppressants Mergers & Acquisitions Activity
Table 15. United States VS China Antiulcer Agents and Acid Suppressants Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Antiulcer Agents and Acid Suppressants in United States, Headquarters (States, Country)
Table 17. United States Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Antiulcer Agents and Acid Suppressants Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Antiulcer Agents and Acid Suppressants in China, Company Headquarters (Province, Country)
Table 20. China Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Antiulcer Agents and Acid Suppressants Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Antiulcer Agents and Acid Suppressants in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Antiulcer Agents and Acid Suppressants Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Antiulcer Agents and Acid Suppressants Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Antiulcer Agents and Acid Suppressants Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Antiulcer Agents and Acid Suppressants Revenue by Type (2017-2022) & (USD Million)
Table 27. World Antiulcer Agents and Acid Suppressants Revenue by Type (2023-2028) & (USD Million)
Table 28. World Antiulcer Agents and Acid Suppressants Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Antiulcer Agents and Acid Suppressants Revenue by Application (2017-2022) & (USD Million)
Table 30. World Antiulcer Agents and Acid Suppressants Revenue by Application (2023-2028) & (USD Million)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Antiulcer Agents and Acid Suppressants Product and Services
Table 34. Pfizer Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Pfizer Recent Developments/Updates
Table 36. Pfizer Competitive Strengths & Weaknesses
Table 37. Sandoz Basic Information, Manufacturing Base and Competitors
Table 38. Sandoz Major Business
Table 39. Sandoz Antiulcer Agents and Acid Suppressants Product and Services
Table 40. Sandoz Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Sandoz Recent Developments/Updates
Table 42. Sandoz Competitive Strengths & Weaknesses
Table 43. Alcon Basic Information, Manufacturing Base and Competitors
Table 44. Alcon Major Business
Table 45. Alcon Antiulcer Agents and Acid Suppressants Product and Services
Table 46. Alcon Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Alcon Recent Developments/Updates
Table 48. Alcon Competitive Strengths & Weaknesses
Table 49. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceuticals Major Business
Table 51. Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
Table 52. Teva Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Teva Pharmaceuticals Recent Developments/Updates
Table 54. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 55. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 56. Sun Pharmaceutical Industries Major Business
Table 57. Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Product and Services
Table 58. Sun Pharmaceutical Industries Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Sun Pharmaceutical Industries Recent Developments/Updates
Table 60. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Major Business
Table 63. Takeda Antiulcer Agents and Acid Suppressants Product and Services
Table 64. Takeda Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Takeda Recent Developments/Updates
Table 66. Takeda Competitive Strengths & Weaknesses
Table 67. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Camber Pharmaceuticals Major Business
Table 69. Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
Table 70. Camber Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Camber Pharmaceuticals Recent Developments/Updates
Table 72. Camber Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Carlsbad Technologies Basic Information, Manufacturing Base and Competitors
Table 74. Carlsbad Technologies Major Business
Table 75. Carlsbad Technologies Antiulcer Agents and Acid Suppressants Product and Services
Table 76. Carlsbad Technologies Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Carlsbad Technologies Recent Developments/Updates
Table 78. Carlsbad Technologies Competitive Strengths & Weaknesses
Table 79. Advagen Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Advagen Pharma Major Business
Table 81. Advagen Pharma Antiulcer Agents and Acid Suppressants Product and Services
Table 82. Advagen Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. Advagen Pharma Recent Developments/Updates
Table 84. Advagen Pharma Competitive Strengths & Weaknesses
Table 85. Gavis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Gavis Pharmaceuticals Major Business
Table 87. Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
Table 88. Gavis Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Gavis Pharmaceuticals Recent Developments/Updates
Table 90. Gavis Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Generic Basic Information, Manufacturing Base and Competitors
Table 92. Generic Major Business
Table 93. Generic Antiulcer Agents and Acid Suppressants Product and Services
Table 94. Generic Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Generic Recent Developments/Updates
Table 96. Generic Competitive Strengths & Weaknesses
Table 97. Akorn Basic Information, Manufacturing Base and Competitors
Table 98. Akorn Major Business
Table 99. Akorn Antiulcer Agents and Acid Suppressants Product and Services
Table 100. Akorn Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Akorn Recent Developments/Updates
Table 102. Akorn Competitive Strengths & Weaknesses
Table 103. Lannett Basic Information, Manufacturing Base and Competitors
Table 104. Lannett Major Business
Table 105. Lannett Antiulcer Agents and Acid Suppressants Product and Services
Table 106. Lannett Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Lannett Recent Developments/Updates
Table 108. Lannett Competitive Strengths & Weaknesses
Table 109. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Lupin Pharmaceuticals Major Business
Table 111. Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
Table 112. Lupin Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. Lupin Pharmaceuticals Recent Developments/Updates
Table 114. Lupin Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Methaparm Basic Information, Manufacturing Base and Competitors
Table 116. Methaparm Major Business
Table 117. Methaparm Antiulcer Agents and Acid Suppressants Product and Services
Table 118. Methaparm Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Methaparm Recent Developments/Updates
Table 120. Methaparm Competitive Strengths & Weaknesses
Table 121. Nostrum Laboratories Basic Information, Manufacturing Base and Competitors
Table 122. Nostrum Laboratories Major Business
Table 123. Nostrum Laboratories Antiulcer Agents and Acid Suppressants Product and Services
Table 124. Nostrum Laboratories Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Nostrum Laboratories Recent Developments/Updates
Table 126. Nostrum Laboratories Competitive Strengths & Weaknesses
Table 127. Precision Dose Basic Information, Manufacturing Base and Competitors
Table 128. Precision Dose Major Business
Table 129. Precision Dose Antiulcer Agents and Acid Suppressants Product and Services
Table 130. Precision Dose Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 131. Precision Dose Recent Developments/Updates
Table 132. Precision Dose Competitive Strengths & Weaknesses
Table 133. Athenex Basic Information, Manufacturing Base and Competitors
Table 134. Athenex Major Business
Table 135. Athenex Antiulcer Agents and Acid Suppressants Product and Services
Table 136. Athenex Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 137. Athenex Recent Developments/Updates
Table 138. Athenex Competitive Strengths & Weaknesses
Table 139. AuroMedics Pharma Basic Information, Manufacturing Base and Competitors
Table 140. AuroMedics Pharma Major Business
Table 141. AuroMedics Pharma Antiulcer Agents and Acid Suppressants Product and Services
Table 142. AuroMedics Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 143. AuroMedics Pharma Recent Developments/Updates
Table 144. AuroMedics Pharma Competitive Strengths & Weaknesses
Table 145. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 146. Fresenius Kabi Major Business
Table 147. Fresenius Kabi Antiulcer Agents and Acid Suppressants Product and Services
Table 148. Fresenius Kabi Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 149. Fresenius Kabi Recent Developments/Updates
Table 150. Fresenius Kabi Competitive Strengths & Weaknesses
Table 151. Astra Zeneca Pharm Basic Information, Manufacturing Base and Competitors
Table 152. Astra Zeneca Pharm Major Business
Table 153. Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Product and Services
Table 154. Astra Zeneca Pharm Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 155. Astra Zeneca Pharm Recent Developments/Updates
Table 156. Astra Zeneca Pharm Competitive Strengths & Weaknesses
Table 157. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 158. Glenmark Pharmaceuticals Major Business
Table 159. Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Product and Services
Table 160. Glenmark Pharmaceuticals Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 161. Glenmark Pharmaceuticals Recent Developments/Updates
Table 162. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 163. Aurobindo Pharma Major Business
Table 164. Aurobindo Pharma Antiulcer Agents and Acid Suppressants Product and Services
Table 165. Aurobindo Pharma Antiulcer Agents and Acid Suppressants Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 166. Antiulcer Agents and Acid Suppressants Raw Material
Table 167. Key Manufacturers of Antiulcer Agents and Acid Suppressants Raw Materials
Table 168. Antiulcer Agents and Acid Suppressants Typical Distributors
Table 169. Antiulcer Agents and Acid Suppressants Typical Customers

LIST OF FIGURES

Figure 1. Antiulcer Agents and Acid Suppressants Picture
Figure 2. World Antiulcer Agents and Acid Suppressants Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Antiulcer Agents and Acid Suppressants Total Market Size (2017-2028) & (USD Million)
Figure 4. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Region (2017-2028)
Figure 5. United States Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 6. China Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 7. Europe Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 8. Japan Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 11. India Antiulcer Agents and Acid Suppressants Market Size (2017-2028) & (USD Million)
Figure 12. Antiulcer Agents and Acid Suppressants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Antiulcer Agents and Acid Suppressants by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Antiulcer Agents and Acid Suppressants Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Antiulcer Agents and Acid Suppressants Markets in 2021
Figure 17. United States VS China: Antiulcer Agents and Acid Suppressants Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Antiulcer Agents and Acid Suppressants Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Type in 2021
Figure 20. 10 mg
Figure 21. 20 mg
Figure 22. 30 mg
Figure 23. 100 mg
Figure 24. Others
Figure 25. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Type (2017-2028)
Figure 26. World Antiulcer Agents and Acid Suppressants Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 27. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Application in 2021
Figure 28. Hospital
Figure 29. Clinics
Figure 30. Pharmacy
Figure 31. Others
Figure 32. World Antiulcer Agents and Acid Suppressants Market Size Market Share by Application (2017-2028)
Figure 33. Manufacturing Cost Structure Analysis of Antiulcer Agents and Acid Suppressants in 2021
Figure 34. Manufacturing Process Analysis of Antiulcer Agents and Acid Suppressants
Figure 35. Antiulcer Agents and Acid Suppressants Industrial Chain
Figure 36. Distribution Channel Breakdown for Antiulcer Agents and Acid Suppressants Shipments (%): 2017-2028
Figure 37. Direct Channel Pros & Cons
Figure 38. Indirect Channel Pros & Cons
Figure 39. Methodology
Figure 40. Research Process and Data Source


More Publications